Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick M Howard

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Epidemiology of Triple-Negative Breast Cancer: A ReviewFrederick M Howard, Olufunmilayo I Olopade
Plos One|August 12, 2020
Implementation of an automated scheduling tool improves schedule quality and resident satisfactionFrederick M Howard, Catherine A Gao, Christopher Sankey
Breast Cancer Research and Treatment|July 14, 2022
Clinical trials of immunotherapy in triple-negative breast cancerFrederick M Howard, Alexander T Pearson, Rita Nanda
Annals of Surgical Oncology|September 23, 2024
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine EraJincong Q Freeman, Dezheng Huo, Frederick M Howard
Plos One|September 8, 2012
A novel approach for transcription factor analysis using SELEX with high-throughput sequencing (TFAST)Daniel J Reiss, Frederick M Howard, Harry L T Mobley
Expert Opinion on Investigational Drugs|September 27, 2021
The emerging role of immune checkpoint inhibitors for the treatment of breast cancerFrederick M Howard, Dario Villamar, Gong He, et al.
JAMA Network Open|March 30, 2023
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the USSarah Shubeck, Fangyuan Zhao, Frederick M Howard, et al.
Academic Radiology|December 30, 2025
Discordance of Radiologic and Pathologic Complete Response in Patients with Triple-negative Breast Cancer Undergoing Neoadjuvant ChemotherapyAsim Dhungana, Wenji Guo, Dezheng Huo, et al.
NPJ Breast Cancer|May 6, 2023
Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patientsJincong Q Freeman, Sarah Shubeck, Frederick M Howard, et al.
JCO Clinical Cancer Informatics|June 1, 2024
Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023Frederick M Howard, Anran Li, Mark F Riffon, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Epidemiology of Triple-Negative Breast Cancer: A ReviewFrederick M Howard, Olufunmilayo I Olopade
Plos One|August 12, 2020
Implementation of an automated scheduling tool improves schedule quality and resident satisfactionFrederick M Howard, Catherine A Gao, Christopher Sankey
Breast Cancer Research and Treatment|July 14, 2022
Clinical trials of immunotherapy in triple-negative breast cancerFrederick M Howard, Alexander T Pearson, Rita Nanda
Annals of Surgical Oncology|September 23, 2024
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine EraJincong Q Freeman, Dezheng Huo, Frederick M Howard
Plos One|September 8, 2012
A novel approach for transcription factor analysis using SELEX with high-throughput sequencing (TFAST)Daniel J Reiss, Frederick M Howard, Harry L T Mobley
Expert Opinion on Investigational Drugs|September 27, 2021
The emerging role of immune checkpoint inhibitors for the treatment of breast cancerFrederick M Howard, Dario Villamar, Gong He, et al.
JAMA Network Open|March 30, 2023
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the USSarah Shubeck, Fangyuan Zhao, Frederick M Howard, et al.
Academic Radiology|December 30, 2025
Discordance of Radiologic and Pathologic Complete Response in Patients with Triple-negative Breast Cancer Undergoing Neoadjuvant ChemotherapyAsim Dhungana, Wenji Guo, Dezheng Huo, et al.
NPJ Breast Cancer|May 6, 2023
Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patientsJincong Q Freeman, Sarah Shubeck, Frederick M Howard, et al.
JCO Clinical Cancer Informatics|June 1, 2024
Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023Frederick M Howard, Anran Li, Mark F Riffon, et al.
Pageof 6